Subscribe to RSS
DOI: 10.1055/s-0041-1726415
2021 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles
Welcome to the latest of our Eberhard F. Mammen award announcements. As noted in previous editorials ([Table 1]), Thieme Medical and Scientific Publisher, the publisher of Seminars in Thrombosis and Hemostasis (STH), has created the “Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards” in honor of Eberhard F. Mammen ([Fig. 1]) in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades. These awards began in 2009, under two categories, “Most Popular Article Awards” and “Young Investigator Awards.” Accordingly, 2021 represents in excess of 10 years of award presentations ([Table 1]). Current details and conditions of the award can be summarized as follows:
-
Most popular article awards: will be awarded to the authors of the most popular articles published in STH. The awards are determined by the Editor in Chief on the basis of user statistics from Thieme e-Journals from the preceding 2 years. Prefaces, Errata, Letters to the Editor, Editorials, Commentaries, and previous award-winning articles are excluded from further consideration of these awards which currently comprise two categories: one for “Open Access” articles and another for a “General Category.” There are two major cash prizes of U.S. $1,000 for each category. In addition, winners of the “General Category” awards are granted “Open Access” status for these articles thereafter.
-
Young investigator awards: the best presentation or meeting abstract by a young investigator as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of U.S. $1,000 in any year. There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other paper related to the topic of their presentation (or as otherwise agreed) for publication in STH. In general, previous award winners are excluded from a second award to enable more individuals to be recognized. After nominations are received, the awardees are selected by a vote of the Senior Editors of STH. Any potential conflicts of interest are managed by first identifying these, and then excluding those with potential conflicts from voting. Finally, given the current COVID-19 (novel coronavirus disease 2019) pandemic, many international congresses have become virtual meetings, and accordingly, virtual meeting presentations can also be considered for the award.
Further details of the awards and the award winners are posted online ( https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 ), and previous award winner announcements are also available in print ([Table 1]). This includes the recent announcement of the 2020 Young Investigator Awards.[1]
It is, therefore, with great pleasure that we would like to announce the latest winners of the 2021 Eberhard F. Mammen awards for the most popular articles from STH for the period of 2019 to 2020 inclusive.
Publication History
Article published online:
22 April 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Favaloro EJ. 2020 Eberhard F. Mammen award announcements: part II—young investigator awards. Semin Thromb Hemost 2021; 47 (03) 229-237
- 2 Gosselin RC, Adcock D, Dorgalaleh A. et al. International Council for Standardization in Haematology recommendations for hemostasis critical values, tests, and reporting. Semin Thromb Hemost 2020; 46 (04) 398-409
- 3 Gosselin RC, Marlar RA. Preanalytical variables in coagulation testing: setting the stage for accurate results. Semin Thromb Hemost 2019; 45 (05) 433-448
- 4 Page MJ, Pretorius E. A champion of host defense: a generic large-scale cause for platelet dysfunction and depletion in infection. Semin Thromb Hemost 2020; 46 (03) 302-319
- 5 Al-Samkari H, Kuter DJ. Immune thrombocytopenia in adults: modern approaches to diagnosis and treatment. Semin Thromb Hemost 2020; 46 (03) 275-288
- 6 Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost 2020; 46 (07) 763-771
- 7 Harenberg J, Schreiner R, Hetjens S, Weiss C. Detecting anti-IIa and anti-Xa direct oral anticoagulant (DOAC) agents in urine using a DOAC dipstick. Semin Thromb Hemost 2019; 45 (03) 275-284
- 8 Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009; 35 (02) 189-203
- 9 Lippi G, Danese E, Favaloro EJ. Harms and benefits of using aspirin for primary prevention of cardiovascular disease: a narrative overview. Semin Thromb Hemost 2019; 45 (02) 157-163
- 10 Lippi G, Salvagno GL, Gelati M, Poli G, Giavarina D, Favaloro EJ. Analytical assessment of the new Roche Cobas t 711 fully automated coagulation analyzer. Semin Thromb Hemost 2019; 45 (03) 308-314
- 11 Lindholm PF, Ramsey G, Kwaan HC. Passive immunity for coronavirus disease 2019: a commentary on therapeutic aspects including convalescent plasma. Semin Thromb Hemost 2020; 46 (07) 796-803
- 12 van der Vorm LN, Huskens D, Kicken CH. et al. Effects of repeated bouts of exercise on the hemostatic system. Semin Thromb Hemost 2018; 44 (08) 710-722
- 13 Zadow EK, Wundersitz DWT, Hughes DL. et al. Coronavirus (COVID-19), coagulation, and exercise: interactions that may influence health outcomes. Semin Thromb Hemost 2020; 46 (07) 807-814
- 14 Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost 2014; 40 (03) 277-283
- 15 Raskob GE, Angchaisuksiri P, Blanco AN. et al; ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost 2014; 40 (07) 724-735
- 16 Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34 (08) 709-733
- 17 Stufano F, Boscarino M, Bucciarelli P. et al. Evaluation of the utility of von Willebrand factor propeptide in the differential diagnosis of von Willebrand disease and acquired von Willebrand syndrome. Semin Thromb Hemost 2019; 45 (01) 36-42
- 18 Favaloro EJ, Pasalic L, Curnow J. Type 2M and Type 2A von Willebrand disease: similar but different. Semin Thromb Hemost 2016; 42 (05) 483-497
- 19 Lim MS, Indran T, Cummins A. et al. Utility of a nurse-led pathway for patients with acute venous thromboembolism discharged on rivaroxaban: a prospective cohort study. Semin Thromb Hemost 2019; 45 (02) 187-195
- 20 Mannucci PM, Mancuso ME, Santagostino E, Franchini M. Innovative pharmacological therapies for the hemophilias not based on deficient factor replacement. Semin Thromb Hemost 2016; 42 (05) 526-532
- 21 Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008; 34 (08) 772-778
- 22 Iba T, Levi M, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost 2020; 46 (01) 89-95
- 23 Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost 2018; 44 (01) 20-29
- 24 Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 2019; 45 (01) 86-93
- 25 Scharf RE. Drugs that affect platelet function. Semin Thromb Hemost 2012; 38 (08) 865-883
- 26 Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004; 30 (05) 579-589
- 27 Maclachlan KH, Stevens HP, Tran HA, Chunilal SD. Weight-based enoxaparin for venous thromboembolism in obesity gives similar anti-xa levels to patients <100 kg, with no increase in major bleeding. Semin Thromb Hemost 2019; 45 (01) 94-99
- 28 Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003; 29 (05) 435-450
- 29 Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost 2014; 40 (05) 571-576
- 30 Favaloro EJ, Kershaw G, Mohammed S, Lippi G. How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying normal reference intervals and assessing APTT reagents for sensitivity to heparin, lupus anticoagulant, and clotting factors. Semin Thromb Hemost 2019; 45 (01) 22-35
- 31 Marlar RA, Clement B, Gausman J. Activated partial thromboplastin time monitoring of unfractionated heparin therapy: issues and recommendations. Semin Thromb Hemost 2017; 43 (03) 253-260
- 32 Bolliger D, Tanaka KA. Point-of-care coagulation testing in cardiac surgery. Semin Thromb Hemost 2017; 43 (04) 386-396
- 33 Bikdeli B, Abou Ziki MD, Lip GYH. Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review. Semin Thromb Hemost 2017; 43 (08) 849-863
- 34 Mahajan A, Brunson A, White R, Wun T. The epidemiology of cancer-associated venous thromboembolism: an update. Semin Thromb Hemost 2019; 45 (04) 321-325
- 35 Van Cott EM, Roberts AJ, Dager WE. Laboratory monitoring of parenteral direct thrombin inhibitors. Semin Thromb Hemost 2017; 43 (03) 270-276
- 36 Davie EW, Kulman JD. An overview of the structure and function of thrombin. Semin Thromb Hemost 2006; 32 (Suppl. 01) 3-15
- 37 Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost 2016; 42 (07) 717-723
- 38 McEwen BJ. The influence of herbal medicine on platelet function and coagulation: a narrative review. Semin Thromb Hemost 2015; 41 (03) 300-314
- 39 Thachil J. The elusive diagnosis of disseminated intravascular coagulation: does a diagnosis of DIC exist anymore?. Semin Thromb Hemost 2019; 45 (01) 100-107
- 40 Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost 2013; 39 (03) 258-266
- 41 Arachchillage DRJ, Makris M. Inherited thrombophilia and pregnancy complications: should we test?. Semin Thromb Hemost 2019; 45 (01) 50-60
- 42 Lippi G, Gosselin R, Favaloro EJ. Current and emerging direct oral anticoagulants: state-of-the-art. Semin Thromb Hemost 2019; 45 (05) 490-501
- 43 Molhoek JE, de Groot PG, Urbanus RT. The lupus anticoagulant paradox. Semin Thromb Hemost 2018; 44 (05) 445-452
- 44 Anker-Møller T, Troldborg A, Sunde N, Hvas AM. Evidence for the use of tranexamic acid in subarachnoid and subdural hemorrhage: a systematic review. Semin Thromb Hemost 2017; 43 (07) 750-758
- 45 Arachchillage DR, Laffan M. Pathogenesis and management of thrombotic disease in myeloproliferative neoplasms. Semin Thromb Hemost 2019; 45 (06) 604-611
- 46 Grandone E, Ostuni A, Tiscia GL, Marongiu F, Barcellona D. Management of patients taking oral anticoagulants who need urgent surgery for hip fracture. Semin Thromb Hemost 2019; 45 (02) 164-170
- 47 International Council for Standardization in Haematology (ICSH). Accessed January 30, 2021 at: https://icsh.org/
- 48 Favaloro EJ. 2020 Eberhard F. Mammen award announcements: part i-most popular articles. Semin Thromb Hemost 2020; 46 (04) 383-392
- 49 Favaloro EJ, Lippi G. Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19)-part I. Semin Thromb Hemost 2020; 46 (07) 757-762
- 50 Hvas AM, Larsen JB, Pasalic L. Acquired platelet dysfunction-laboratory and clinical implications. Semin Thromb Hemost 2020; 46 (03) 235-237
- 51 Van Cott EM, Smock KJ, Lippi G. Innovations in thrombosis and hemostasis: a glimpse towards the future of diagnostic analyzers. Semin Thromb Hemost 2019; 45 (03) 225-227
- 52 Schulman S. Recent advances in thrombosis and hemostasis-part IV. Semin Thromb Hemost 2019; 45 (02) 130-131
- 53 Favaloro EJ, Lippi G. Editorial compilation VI. Semin Thromb Hemost 2019; 45 (01) 5-9
- 54 Adams MJ, Fell JW. Hemostasis in exercise and the athlete. Semin Thromb Hemost 2018; 44 (08) 707-709
- 55 Favaloro EJ, Lippi G. Editorial compilation V. Semin Thromb Hemost 2018; 44 (03) 193-196
- 56 Favaloro EJ, Lippi G. Editorial compilation VIII. Semin Thromb Hemost 2020; 46 (04) 393-397
- 57 Favaloro EJ, Lippi G. Editorial compilation VII. Semin Thromb Hemost 2019; 45 (05) 429-432
- 58 Kitchen S, Tiefenbacher S, Gosselin R. Factor activity assays for monitoring extended half-life FVIII and factor IX replacement therapies. Semin Thromb Hemost 2017; 43 (03) 331-337
- 59 Favaloro EJ. 2019 Eberhard F. Mammen award announcements: part I-most popular articles. Semin Thromb Hemost 2019; 45 (03) 215-224
- 60 Mammen EF, Comp PC, Gosselin R. et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24 (02) 195-202
- 61 Favaloro EJ. 2017 Eberhard F. Mammen award announcements: part II-young investigator awards. Semin Thromb Hemost 2018; 44 (02) 81-88
- 62 Favaloro EJ. A 2018 update on the editorial and publication policy of seminars in thrombosis and hemostasis. Semin Thromb Hemost 2018; 44 (04) 307-311
- 63 Russo V, Attena E, Mazzone C. et al. Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves/prior surgical valve repair: a multicenter clinical practice experience. Semin Thromb Hemost 2018; 44 (04) 364-369